Antifungal drug resistance: does it matter?
- 1 March 2002
- journal article
- review article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 6, S47-S53
- https://doi.org/10.1016/s1201-9712(02)90154-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- Practice Guidelines for the Treatment of CandidiasisClinical Infectious Diseases, 2000
- Role of dimorphism in the development of Candida albicans biofilmsJournal of Medical Microbiology, 1999
- Interferon γ and Granulocyte‐Macrophage Colony‐Stimulating Factor for the Treatment of Hepatosplenic Candidosis in Patients with Acute LeukemiaClinical Infectious Diseases, 1998
- Symptomatic Vulvovaginitis Due to Fluconazole-Resistant Candida albicans in a Female Who Was Not Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility TestingClinical Infectious Diseases, 1996
- Risk Factors for Fluconazole-Resistant Candidiasis in Human Immunodeficiency Virus-Infected PatientsThe Journal of Infectious Diseases, 1996
- Intravascular Catheter Exchange and Duration of CandidemiaClinical Infectious Diseases, 1995
- DNA Subtypes and Fluconazole Susceptibilities of Candida albicans Isolates from the Oral Cavities of Patients with AIDSClinical Infectious Diseases, 1995
- Amphotericin B-resistant yeast infection in severely immunocompromised patientsThe American Journal of Medicine, 1988